Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA
HELSINKI, Finland, March 23, 2022 /PRNewswire/ -- Inside information Nanoform Finland Plc March 22, 2022 23:45 Finnish time / 22:45 Swedish time Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA,...
InnoCare Releases 2021 Annual Results and Business Highlights
BEIJING, March 23, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2021 annual results as of 31 December 2021. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, "We are delighted to announce 2021 results on the occasion of our 2nd anniversary of listing on Hong...
VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease
SHANGHAI, March 23, 2022 /PRNewswire/ -- VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of innovative therapies for ocular diseases, today announced positive topline results from a Phase 2 clinical study of VVN001 in patients with dry eye disease. The randomized, double-masked, vehicle-controlled Phase 2 clinical study was...
Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results
– Advancing key programs in HBV, CNS, and HIV – – Received first BLA approval for COVID-19 Treatment in China and added to China's latest COVID-19 Diagnosis and Treatment Guidelines– – Multiple clinical value drivers expected across the portfolio in 2022 and beyond – – Cash, bank balances, and potential...
Arum Therapeutics implements CDD Vault to streamline its research data and collaboration workflows.
SEOUL, South Korea and BURLINGAME, Calif., March 23, 2022 /PRNewswire/ -- Arum Therapeutics Inc. (Arum), a leading pharmaceutical company that specializes in the discovery of new molecules and molecule combinations to target novel oncology announced today that it had implemented CDD Vault, a research data management platform developed by Collaborative Drug Discovery,...
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively
The Proportion of Revenue from Innovative Products Continues to Increase Highlights: Revenue for the year ended December 31, 2021 was RMB39,005 million, representing an increase of 28.70% YOY; The proportion of revenue from new products as well as regions outside Mainland China and countries overseas continue to increase, continuously optimizing the revenue structure; In 2021, the...
Servatus launches Australia’s first human study into the effects of live biotherapeutics on insomnia
Study to look at the link between the gut microbiome and sleep, by treating patients who suffer from insomnia with live biotherapeutics Phase I/II trial will run during 2022, with results expected in 2023 Close to 15% of the Australian population suffer from insomnia, with sleep disorders costing the economy and society around $51 billion annually...
WuXi Biologics Achieved Record Growth and Profitability in 2021
Banner Year for Commercial Manufacturing Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million Gross Profit Increased by 90.6% Y-o-Y to RMB4,828.9 Million Net Profit Grew by 107.3% Y-o-Y to RMB3,508.6 Million Adjusted Net Profit Rose by 100.3% to RMB3,435.9 MillionTotal Backlog Grew 20.1% to US$13,597 Million * * * CRDMO Business Model Created Sustainable Long-term GrowthExecution of Our Strategies...
INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use
GARDEN GROVE, Calif., March 23, 2022 /PRNewswire/ -- PHASE Scientific International, LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on March 16, 2022. The FDA authorized the test for non-prescription home use in the U.S....
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83%
BEIJING and SHANGHAI and BOSTON, March 22, 2022 /PRNewswire/ -- Jacobio Announced its 2021 annual results on 22 March. As a clinical-stage biotech company, Jacobio's revenue was RMB152 million, which was generated from an out-licensing deal. Its R&D investment was RMB421 million, showing an increase of 83% compared with 2021. "83% growth was...
